Dominick & Dominick’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q4
$464K Buy
7,859
+2,145
+38% +$121K 0.24% 119
2014
Q3
$292K Hold
5,714
0.14% 134
2014
Q2
$277K Sell
5,714
-56
-1% -$2.76K 0.13% 139
2014
Q1
$300K Buy
5,770
+1
+0% +$53 0.15% 142
2013
Q4
$307K Buy
5,769
+2
+0% +$102 0.15% 146
2013
Q3
$267K Buy
5,767
+116
+2% +$5.09K 0.15% 142
2013
Q2
$253K Buy
+5,651
New +$245K 0.15% 140

Other funds holding BMY

Dominick & Dominick's BMY Position: Q4 2014 in Review

Dominick & Dominick increased its Bristol-Myers Squibb (BMY) stake by 38% in Q4 2014, buying an estimated $121K and bringing the position to 7,859 shares worth $464K. The position accounts for 0.24% of the portfolio, ranked #119.

Dominick & Dominick first reported a position in BMY in Q2 2013 and has held it in 7 quarters since. 1,410 funds tracked by Wall St. Rank hold BMY as of Q4 2014.

  • Dominick & Dominick held 7,859 shares of Bristol-Myers Squibb worth $464K as of Q4 2014.
  • Dominick & Dominick bought 2,145 Bristol-Myers Squibb shares in Q4 2014, an estimated $121K.
  • Bristol-Myers Squibb made up 0.24% of Dominick & Dominick's portfolio in Q4 2014, its #119 holding.
  • Dominick & Dominick first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 7 quarters since.
  • 1,410 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2014.

Based on Dominick & Dominick's 13F filing for Q4 2014, filed 22 Jan 2015.